We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01643304
Recruitment Status : Completed
First Posted : July 18, 2012
Last Update Posted : November 21, 2013
Information provided by (Responsible Party):

July 16, 2012
July 18, 2012
November 21, 2013
May 2012
Not Provided
Prevalence of subjectively experienced heavy menstrual bleeding assessed by questionnaire [ Time Frame: Once at baseline ]
Same as current
Complete list of historical versions of study NCT01643304 on ClinicalTrials.gov Archive Site
  • Social consequences of heavy menstrual bleedings assessed by questionnaire [ Time Frame: Once at baseline ]
  • Costs; e.g. pads, absence from work, loss of income assessed by questionnaire [ Time Frame: Once at baseline ]
  • The treatments given for heavy menstrual bleedings, as surgery or medication assessed by questionnaire [ Time Frame: Once at baseline ]
Same as current
Not Provided
Not Provided
A Swedish Questionnaire Study to Investigate the Perception of Menstrual Bleedings
A Swedish Cross-sectional Study With Questionnaire to Investigate Perception of Menstrual Bleeding
This field based, questionnaire study will document observational data on womens perception of menstrual bleeding in a cross-section of women in Sweden. Each subject will complete the questionnaire at one occasion.
Not Provided
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
Subjects included in the SIFO (Swedish institute of market research) volontary subject pool.
Behavioral: No drug
No drug intervention. The intervention is a questionnaire with quality of life and perception of menstrual bleedings. All subjects will complete both questionnaires.
Group 1
Intervention: Behavioral: No drug
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
June 2012
Not Provided

Inclusion Criteria:

  • All women 40-45 years available in the web-panel of SIFO
  • Completion of the web-based questionnaire

Exclusion Criteria:

Sexes Eligible for Study: Female
40 Years to 45 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
NN1223SE ( Other Identifier: Company Internal )
Not Provided
Not Provided
Not Provided
Study Director: Bayer Study Director Bayer
November 2013